Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 17/20 | 0.44 |
| ▸ | MMP9 | P14780 | 15/20 | 0.44 |
| ▸ | MMP1 | P03956 | 4/20 | 0.43 |
| ▸ | MMP3 | P08254 | 4/20 | 0.43 |
| ▸ | MMP7 | P09237 | 4/20 | 0.43 |
| ▸ | MMP13 | P45452 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | ADAMTS4 | O75173 | 2/20 | 0.39 |
| ▸ | MMP8 | P22894 | 4/20 | 0.37 |
| ▸ | MMP12 | P39900 | 4/20 | 0.37 |
| ▸ | MMP14 | P50281 | 4/20 | 0.37 |
| ▸ | BCL2 | P10415 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7675980 | 0.94 | MMP2 (0.41) | MMP2MMP9MMP1MMP3MMP7 | |
| SCHEMBL6073739 | 0.86 | MMP2 (0.61) | MMP2MMP9MMP1MMP3MMP7 | |
| SCHEMBL4654917 | 0.81 | MMP2 (0.56) | MMP2MMP9MMP1MMP3MMP7 | |
| SCHEMBL6889607 | 0.80 | SMN1; SMN2 (0.35) | — | |
| SCHEMBL5139951 | 0.79 | MMP2 (0.62) | MMP2MMP9MMP1MMP3MMP7 | |
| SCHEMBL4958777 | 0.79 | MMP2 (0.62) | MMP2MMP9MMP1MMP3MMP7 | |
| SCHEMBL7167308 | 0.76 | MMP2 (0.50) | MMP2MMP9MMP1MMP3MMP7 | |
| SCHEMBL7676093 | 0.75 | SMN1; SMN2 (0.34) | — | |
| SCHEMBL14289008 | 0.73 | MMP2 (0.57) | MMP2MMP9MMP1MMP3MMP7 | |
| SCHEMBL7041551 | 0.72 | ITGAV (0.53) | MMP2MMP9ALDH1A1MMP8MMP12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6683163-B2 | MONITORING ANGIOGENESIS FACTOR | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2004-01-27 | — | — | US | disclosed |